BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

TLRY

Tilray Brands, Inc.
Nasdaq · Medicinal chemicals & botanical products (SIC 2833) · FY ends 31 May

Revenue, quarterly

$257M+22.7% year on year
$300M$200M$100M$0
Q2 ’22Q3 ’23Q4 ’24Q4 ’25Q1 ’27
Company filings · 10-Q filed 8 Oct 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

29.1%+0.4 pp year on year
40%30%20%10%
Q2 ’22Q3 ’23Q4 ’24Q4 ’25Q1 ’27
Company filings · 10-Q filed 8 Oct 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$215M−18.8% year on year
$600M$400M$200M$0
Q2 ’22Q3 ’23Q4 ’24Q4 ’25Q1 ’27
Company filings · 10-Q filed 8 Oct 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$128M
$100M$0−$100M−$200M−$300M
Q3 ’20Q2 ’22Q3 ’23Q3 ’24Q4 ’25
Company filings · 10-K filed 28 Jul 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty